Stephen R. LaNeve
President, CEO & DirectorMr. Stephen R. LaNeve, also known as Steve, MBA, has been the President, Chief Executive Officer and Director of Accuray Incorporated since October 20, 2025. Mr. LaNeve joined the Accuray Incorporated on October 20, 2025. He has been Chief Executive Officer and President at Etex Corporation since January 7, 2014. Mr. LaNeve served as Chief Executive Officer and President of Bone Biologics Corporation from August 17, 2015 to June 28, 2019 and was its Director since 2015 until December 18, 2022. Mr. LaNeve is the co-Founder of SkelRegen and serves as its Chief Executive Officer. He served as the President of Spinal and Biologics Business and Senior Vice President of Medtronic Inc., since April 2008. He had responsibility for the continued integration of Kyphon, the biologics business and the core spine business. Mr. LaNeve served as the President of Medtronic Japan. He has healthcare industry experience during which he served in various leadership roles in the medical device and diagnostics segments. Most recently, he served as President of Becton Dickinson’s Pre-Analytical Systems business. He served in a number of commercial leadership positions at Roche Diagnostics, E Merck Diagnostic Systems and in Becton Dickinson’s Point of Care Division. In these positions, he led sales, marketing, strategic planning and project management efforts both in the U.S. and internationally. He serves as Director of Rapid Pathogen Screening, Inc. He most recently served as President of the Trauma and Joint Reconstruction business unit of Globus Medical Inc. and previously, Globus Medical Japan K.K., a provider of musculoskeletal device solutions, from 2019 to 2024. From 2015 to 2019, Mr. La Neve was CEO of Bone Biologics Corporation, a medical device company focused on bone regeneration. He also served as a member of the board of directors of Bone Biologics Corporation until December 2022. Prior to that, Mr. La Neve served as CEO of Life Science Enterprises Inc., an early-stage biomaterials company spun out from ETEX Corporation, from 2014 to 2015 and CEO of ETEX Corporation, an advanced biomaterials company, from 2014 until Zimmer Holdings Inc. acquired the business of ETEX Holdings Inc. late in 2014. Prior to that role, Mr. La Neve was CEO and a member of the board of directors at SkelRegen, LLC, Global President of Becton Dickinson Preanalytical Systems, Global President of Medtronic Spine and Biologics Inc., as well as President of Medtronic Japan. Early in his career, Mr. La Neve served in various commercial roles for three diagnostics companies: Becton Dickinson, Roche and EM Diagnostic Systems, domestically and internationally. He has served as a board member for several healthcare companies in the medical device and diagnostic segments, currently including Insight Medbotics, a company developing MRI guided robotics for interventional oncology. Mr. La Neve holds a B.S. in Health Planning and Administration from the Pennsylvania State University and an MBA from West Chester University. He is a member of Omicron Delta Epsilon, an international honor society recognizing academic excellence and achievements in economics.
Positions
- Company NameAccuray IncorporatedStock CodeARAYPositionPresident, CEO & DirectorColleagues
- JEJoseph E. WhittersIndependent Chairman of the Board
- APAli PervaizSenior VP & CFO
- PMPaul MieleSenior VP & Chief Commercial Officer
- MJMichael J. MurphyCorporate Controller & Principal Accounting Officer
- DSDavid ShinSenior VP, Chief Legal Officer & Corporate Secretary
- JMJames M. HindmanIndependent Director
- MNMika NishimuraIndependent Director
- SFSteven Francis MayerDirector
